of Screening Compounds
Drug Discovery Services
Pharma News, 2019
FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk
EMA update on metformin diabetes medicines
EMA is aware that trace amounts of an impurity, N-nitrosodimethylamine (NDMA), have been found in a small number of metformin diabetes medicines outside the EU.
Research shows the pharma industry believes AI will likely optimise R&D
A survey has shown that the pharmaceutical industry believes R&D will see a lot of benefit from digital transformation and that AI will be at the forefront of this.
Zotiraciclib granted Orphan Drug Designation by FDA and EMA
The FDA and EMA have granted Orphan Drug Designation to zotiraciclib, currently the subject of two separate Phase Ib clinical trials in glioblastoma.
Scientists Create a New Kind of Artificial Flesh That Heals Itself Like The Real Thing
Artificial flesh is growing ever closer to the real thing.
FDA expands use of insulin glargine to childhood diabetes
FDA expanded the indication for insulin glargine 300 units/mL injection (Toujeo—Sanofi) to include children as young as age 6 years with type 1 diabetes.
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
SAN DIEGO, Dec.
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
PARIS and San Diego, California – December 9, 2019 – Sanofi and Synthorx, Inc.
A step toward an Alzheimer's treatment? New ultrasound can cuts through the blood-brain barrier to target dementia-linked plaques
Scientists have taken a step toward treating Alzheimer's by gaining access to hard-to-reach areas of the brain that they believe drugs to repair the disease's damage need to target, a new stud...
Scientists discover molecule that destroys pancreatic cancer cells
A little molecule named PJ34 can cause cancer cells to self-destruct, according to an Israeli study published recently in the biomedical journal Oncotarget.
Study: Aspirin anti-cancer
A study conducted by the US National Institutes of Health showed that small doses of aspirin may increase the chances of overcoming cancer.
Bristol-Myers Squibb gets FDA breakthrough therapy status for Orencia to prevent GvHD
Bristol-Myers Squibb (BMS) has secured breakthrough therapy status from the US Food and Drug Administration (FDA) for its Orencia (abatacept) to prevent moderate to severe acut...
Go to cart
You will be able to Pay Online or Request a Quote
Catalog of Screening Compounds
Focused and Target Libraries
Active Reference Sets
Drug Discovery Services
In silico Drug Design (CADD)
Toxicology and Safety
Chemistry, Manufacturing and Controls
News & Media
Trends in discovery compounds